Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry
Diabetic kidney disease (DKD) is the major cause of end stage renal disease in patients with type 2 diabetes mellitus (T2DM). The subtle metabolic changes in plasma and cerebrospinal fluid (CSF) might precede the development of DKD by years. In this longitudinal study, CSF and plasma samples were co...
Main Authors: | Huan-Tang Lin, Mei-Ling Cheng, Chi-Jen Lo, Gigin Lin, Fu-Chao Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/11/2626 |
Similar Items
-
Exploring the aging process of cognitively healthy adults by analyzing cerebrospinal fluid metabolomics using liquid chromatography-tandem mass spectrometry
by: Fu-Chao Liu, et al.
Published: (2023-04-01) -
Metabolomics Signature in Prediabetes and Diabetes: Insights From Tandem Mass Spectrometry Analysis
by: Saad Ayyal Jabbar Al‐Rikabi, et al.
Published: (2024-05-01) -
Liquid chromatography coupled to mass spectrometry metabolomic analysis of cerebrospinal fluid revealed the metabolic characteristics of moyamoya disease
by: Jin Yu, et al.
Published: (2024-02-01) -
Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing
by: Henrik Carlsson, et al.
Published: (2021-02-01) -
Advanced Mass Spectrometry-Based Biomarker Identification for Metabolomics of Diabetes Mellitus and Its Complications
by: Feixue Zhang, et al.
Published: (2024-05-01)